Mylan, Pfizer say Mylan-Upjohn combined entity to be known as Viatris Medical Dialogues Bureau16 Nov 2019 9:20 AM ISTNew Delhi: Mylan N.V. and Pfizer Inc. recently announced that the name of the new company to be formed by the planned combination of Mylan and Upjohn,...
NPPA fixes retail price of 14 drug formulations; Details Farhat Nasim13 Nov 2019 11:23 AM ISTNew Delhi: Through a recent notification, the apex drug price regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the...
Novartis gets U.S. nod for long-delayed copycat version of Amgen billion seller Neulasta drug Medical Dialogues Bureau6 Nov 2019 10:32 AM ISTZURICH: Novartis on Tuesday won U.S. approval for its long-delayed version of Amgen's $4 billion seller Neulasta drug, helping the Swiss drugmaker in...
Pfizer cancer drug Ibrance higher sales beat Q3 profit estimates Medical Dialogues Bureau30 Oct 2019 9:30 AM ISTPfizer said it expects to earn between $2.94 per share and $3.00 per share, up from a prior estimate of $2.76 to $2.86. Analysts on average were...
Mylan moves application with DCGI to launch new TB drug Pretomanid in India Medical Dialogues Bureau16 Oct 2019 4:10 PM IST"We have submitted the new drug application to the office of DCGI. We are in an advanced stage of discussion and are working with the office of...
Biocon, Mylan launch insulin biosimilar Semglee in Australia Medical Dialogues Bureau3 Oct 2019 3:51 PM ISTNew Delhi: Biotechnology major Biocon and pharmaceutical company Mylan N V on Thursday announced the launch of their insulin biosimilar Semglee,...
Mylan to infuse USD 1 billion on capex in India Medical Dialogues Bureau30 Sept 2019 9:30 AM ISTMylan Global President and Executive Director Rajiv Malik said the company had been investing close to about USD 400 million or USD 450 million...
Mylan launches generic version of Faslodex Injection to treat breast cancer Medical Dialogues Bureau19 Sept 2019 9:35 AM ISTNew Delhi: Mylan N.V. recently announced the U.S. launch of Fulvestrant Injection, 250 mg/5 mL (50 mg/mL) per single-dose prefilled syringe, a generic...
Mylan gets tentative USFDA nod for generic of Eli Lilly lung cancer drug Alimta Medical Dialogues Bureau31 Aug 2019 9:30 AM ISTAlimta is Lilly's third biggest-selling drug. The Indianapolis-based drugmaker reported second-quarter sales of $577.8 million for the medicine.U.S:...
Pfizer infuses Rs 3597 crore to expand gene therapy plant in Sanford Medical Dialogues Bureau22 Aug 2019 9:30 AM ISTThe investment will add additional capacity and capabilities to a facility that makes some of Pfizer's most closely watched experimental...
Pfizer, Mylan in talks to merge off-patent drugs business Medical Dialogues Bureau29 July 2019 9:30 AM ISTMylan shareholders would receive a little more than 40 per cent of the newly formed entity, with Pfizer shareholders receiving the remainder, the...
DOP rejects Mylan review application for revising retail price of Hepatitis B, HIV drug Farhat Nasim18 July 2019 3:58 PM ISTNew Delhi: Through a recent decision, the Department of Pharmaceuticals has rejected the review application filed by Mylan Pharmaceuticals Private...
